HR. 2821Introduced
FDA Modernization Act 3.0
Modernize FDA preclinical testing pathways by expanding non-animal methods for drug and biological product development and review
Plain-English overview
What this bill does
Modernize FDA preclinical testing pathways by expanding non-animal methods for drug and biological product development and review
Key points
- Expand non animal testing methods
Current status
Where it stands
Status
Introduced
Latest action
2026-06-18 — Placed on the Union Calendar, Calendar No. 614.
Related context
Topics and policy areas
undefinedAdministrative law and regulatory proceduresDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationHealthMedical researchResearch administration and funding